Caladrius Biosciences, Inc. (LSTA) Tops Q2 EPS by 20c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q2 EPS of ($0.50), $0.20 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c